TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
2,162
|
1,389 |
Financial expenses |
21
|
0
![]() |
0 |
Earnings before taxes |
-13
|
1,426
|
830 |
EBITDA |
-30
|
1,424
|
831 |
Total assets |
2,227
|
2,518
|
1,338 |
Current assets |
2,227
|
2,493
|
1,313 |
Current liabilities |
242
|
516
|
299 |
Equity capital |
1,955
|
1,969
|
1,039 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
87.8%
|
78.2%
|
77.7% |
Turnover per employee |
0
|
2,162
|
1,389 |
Profit as a percentage of turnover |
66.0%
|
59.8% | |
Return on assets (ROA) |
0.4%
|
56.6%
|
62.0% |
Current ratio |
920.2%
|
483.1%
|
439.1% |
Return on equity (ROE) |
-0.7%
|
72.4%
|
79.9% |
Change turnover |
-2,162
|
773
|
1,264 |
Change turnover % |
-100%
|
56%
|
1011% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.